Other immunohistochemical markers that may be focally positive and heterogeneous in tumor cells include desmin, CD68, vimentin, glypican‐3, and CD10, whereas myogenin, S‐100 protein, CD117, and HepPar 1 should be negative. This evidence concerns the gene DES and neoplasm.